2015
Marijuana Legalization: Impact on Physicians and Public Health
Wilkinson ST, Yarnell S, Radhakrishnan R, Ball SA, D'Souza DC. Marijuana Legalization: Impact on Physicians and Public Health. Annual Review Of Medicine 2015, 67: 1-14. PMID: 26515984, PMCID: PMC4900958, DOI: 10.1146/annurev-med-050214-013454.BooksConceptsNausea/vomitingRobust clinical evidenceCertain public health issuesPublic health impactPublic health issuePublic healthHigh rateMarijuana useDependence/addictionLegitimate medical useNeuropathic painOpioid useClinical evidenceMultiple sclerosisPulmonary disordersUnintentional ingestionHealth problemsTherapeutic promiseAcute marijuana intoxicationHealth issuesMarijuana intoxicationRecreational useHealth impactsMarijuana productsCannabinoids
2013
Spicing things up: synthetic cannabinoids
Spaderna M, Addy PH, D’Souza D. Spicing things up: synthetic cannabinoids. Psychopharmacology 2013, 228: 525-540. PMID: 23836028, PMCID: PMC3799955, DOI: 10.1007/s00213-013-3188-4.Peer-Reviewed Original ResearchCommentary on Hermanns‐Clausen et al. (2013): Spicing things up – the emerging phenomenon of synthetic cannabinoid use
Addy PH, D'Souza D. Commentary on Hermanns‐Clausen et al. (2013): Spicing things up – the emerging phenomenon of synthetic cannabinoid use. Addiction 2013, 108: 545-546. PMID: 23418659, DOI: 10.1111/add.12098.Peer-Reviewed Original Research
2012
Dose-Related Behavioral, Subjective, Endocrine, and Psychophysiological Effects of the κ Opioid Agonist Salvinorin A in Humans
Ranganathan M, Schnakenberg A, Skosnik PD, Cohen BM, Pittman B, Sewell RA, D'Souza DC. Dose-Related Behavioral, Subjective, Endocrine, and Psychophysiological Effects of the κ Opioid Agonist Salvinorin A in Humans. Biological Psychiatry 2012, 72: 871-879. PMID: 22817868, PMCID: PMC3638802, DOI: 10.1016/j.biopsych.2012.06.012.Peer-Reviewed Original ResearchMeSH KeywordsAdministration, InhalationAdultCardiovascular SystemCognitionCross-Over StudiesDiterpenes, ClerodaneDose-Response Relationship, DrugDrug MonitoringElectroencephalographyEuphoriaFemaleHallucinogensHumansHydrocortisoneIllicit DrugsMalePerceptionProlactinPsychiatric Status Rating ScalesPsychoses, Substance-InducedReceptors, Opioid, kappaSensationConceptsSA administrationSalvinorin APopular recreational drugElectroencephalogram spectral powerPrimary active ingredientPsychotomimetic effectsReceptor agonismOpiate receptorsEndocrine effectsHealthy subjectsSelective agonistHealthy individualsPerceptual alterationsPlasma cortisolEuphoric effectsCognitive deficitsRecreational drugsVital signsCounterbalanced studyEffect of SAYoung adultsAdverse effectsPsychophysiological effectsIndividual variabilityAdministration